

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 9.26813122 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 9.26813122 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.94699129 |
| 4 | protein retention in ER lumen (GO:0006621) | 6.43288188 |
| 5 | COPII vesicle coating (GO:0048208) | 5.98914211 |
| 6 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 5.31487868 |
| 7 | vesicle coating (GO:0006901) | 5.06402989 |
| 8 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 4.89474567 |
| 9 | positive regulation of nuclease activity (GO:0032075) | 4.63495015 |
| 10 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.22233508 |
| 11 | protein maturation by protein folding (GO:0022417) | 4.21572929 |
| 12 | exocrine pancreas development (GO:0031017) | 4.19505473 |
| 13 | regulation of nuclease activity (GO:0032069) | 4.17002275 |
| 14 | cellular response to unfolded protein (GO:0034620) | 4.04693727 |
| 15 | ER-nucleus signaling pathway (GO:0006984) | 3.96768986 |
| 16 | L-serine transport (GO:0015825) | 3.90321271 |
| 17 | positive regulation of mitochondrial fission (GO:0090141) | 3.89628341 |
| 18 | cellular response to topologically incorrect protein (GO:0035967) | 3.86441374 |
| 19 | peptide hormone processing (GO:0016486) | 3.73397168 |
| 20 | membrane budding (GO:0006900) | 3.64530095 |
| 21 | response to endoplasmic reticulum stress (GO:0034976) | 3.55641542 |
| 22 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.53636069 |
| 23 | cellular response to vitamin D (GO:0071305) | 3.46404829 |
| 24 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.45975768 |
| 25 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.45152017 |
| 26 | intestinal epithelial cell development (GO:0060576) | 3.40333461 |
| 27 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.39966679 |
| 28 | toxin metabolic process (GO:0009404) | 3.36523421 |
| 29 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.36133853 |
| 30 | serine transport (GO:0032329) | 3.29416448 |
| 31 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.29121893 |
| 32 | cullin deneddylation (GO:0010388) | 3.28503824 |
| 33 | peptidyl-cysteine modification (GO:0018198) | 3.28469985 |
| 34 | endocrine pancreas development (GO:0031018) | 3.24797774 |
| 35 | signal peptide processing (GO:0006465) | 3.22503500 |
| 36 | sequestering of metal ion (GO:0051238) | 3.19503489 |
| 37 | response to unfolded protein (GO:0006986) | 3.18763363 |
| 38 | cholesterol biosynthetic process (GO:0006695) | 3.17943548 |
| 39 | ribonucleoprotein complex disassembly (GO:0032988) | 3.17387446 |
| 40 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.14697424 |
| 41 | peptidyl-asparagine modification (GO:0018196) | 3.13707602 |
| 42 | regulation of early endosome to late endosome transport (GO:2000641) | 3.13545573 |
| 43 | proteasome assembly (GO:0043248) | 3.12264426 |
| 44 | 4-hydroxyproline metabolic process (GO:0019471) | 3.11611647 |
| 45 | cellular response to vitamin (GO:0071295) | 3.09625417 |
| 46 | response to topologically incorrect protein (GO:0035966) | 3.07120911 |
| 47 | nucleobase catabolic process (GO:0046113) | 3.06239806 |
| 48 | protein deneddylation (GO:0000338) | 3.00770887 |
| 49 | ER overload response (GO:0006983) | 3.00670044 |
| 50 | sterol biosynthetic process (GO:0016126) | 2.99792452 |
| 51 | * ER to Golgi vesicle-mediated transport (GO:0006888) | 2.98517774 |
| 52 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.97079884 |
| 53 | protein localization to cilium (GO:0061512) | 2.92460908 |
| 54 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.86723324 |
| 55 | protein N-linked glycosylation (GO:0006487) | 2.85166694 |
| 56 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.83534615 |
| 57 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.83534615 |
| 58 | macroautophagy (GO:0016236) | 2.83401191 |
| 59 | peptidyl-proline hydroxylation (GO:0019511) | 2.79848778 |
| 60 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.78236765 |
| 61 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.72750230 |
| 62 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.72656822 |
| 63 | positive regulation of glycolytic process (GO:0045821) | 2.71282318 |
| 64 | insulin secretion (GO:0030073) | 2.70923092 |
| 65 | fatty acid elongation (GO:0030497) | 2.70211916 |
| 66 | intestinal absorption (GO:0050892) | 2.69360799 |
| 67 | glandular epithelial cell differentiation (GO:0002067) | 2.67768744 |
| 68 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.67683060 |
| 69 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.66802220 |
| 70 | platelet dense granule organization (GO:0060155) | 2.66677845 |
| 71 | keratinocyte development (GO:0003334) | 2.66411615 |
| 72 | transferrin transport (GO:0033572) | 2.66365748 |
| 73 | * establishment of melanosome localization (GO:0032401) | 2.64301225 |
| 74 | apoptotic cell clearance (GO:0043277) | 2.64172728 |
| 75 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.62616910 |
| 76 | protein hydroxylation (GO:0018126) | 2.61913845 |
| 77 | positive regulation of actin filament depolymerization (GO:0030836) | 2.61515702 |
| 78 | tricarboxylic acid metabolic process (GO:0072350) | 2.60154383 |
| 79 | cellular response to nutrient (GO:0031670) | 2.58015332 |
| 80 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.57906401 |
| 81 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.57906401 |
| 82 | membrane repolarization during action potential (GO:0086011) | 2.57766660 |
| 83 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.57105430 |
| 84 | polarized epithelial cell differentiation (GO:0030859) | 2.56648013 |
| 85 | negative regulation of fatty acid transport (GO:2000192) | 2.56404402 |
| 86 | lipid particle organization (GO:0034389) | 2.56222188 |
| 87 | * melanosome transport (GO:0032402) | 2.55923329 |
| 88 | positive regulation of insulin secretion (GO:0032024) | 2.55561757 |
| 89 | organelle disassembly (GO:1903008) | 2.55003967 |
| 90 | * Golgi organization (GO:0007030) | 2.54630764 |
| 91 | * establishment of pigment granule localization (GO:0051905) | 2.52868282 |
| 92 | intestinal cholesterol absorption (GO:0030299) | 2.52208954 |
| 93 | cellular zinc ion homeostasis (GO:0006882) | 2.50718772 |
| 94 | regulation of coenzyme metabolic process (GO:0051196) | 2.50301902 |
| 95 | regulation of cofactor metabolic process (GO:0051193) | 2.50301902 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 2.50220876 |
| 97 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.50177923 |
| 98 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.47360650 |
| 99 | type B pancreatic cell proliferation (GO:0044342) | 2.47143926 |
| 100 | ganglion development (GO:0061548) | 2.46310052 |
| 101 | endoplasmic reticulum organization (GO:0007029) | 2.46039697 |
| 102 | cell adhesion mediated by integrin (GO:0033627) | 2.45815592 |
| 103 | nitric oxide mediated signal transduction (GO:0007263) | 2.44974457 |
| 104 | * pigment granule transport (GO:0051904) | 2.44344907 |
| 105 | zinc ion transport (GO:0006829) | 2.43725056 |
| 106 | ferric iron transport (GO:0015682) | 2.43118050 |
| 107 | trivalent inorganic cation transport (GO:0072512) | 2.43118050 |
| 108 | cellular response to glucose starvation (GO:0042149) | 2.42863582 |
| 109 | glycosphingolipid biosynthetic process (GO:0006688) | 2.42382179 |
| 110 | * Golgi vesicle transport (GO:0048193) | 2.41773474 |
| 111 | isoprenoid biosynthetic process (GO:0008299) | 2.40217818 |
| 112 | hormone catabolic process (GO:0042447) | 2.39773209 |
| 113 | nitric oxide biosynthetic process (GO:0006809) | 2.39438040 |
| 114 | hippo signaling (GO:0035329) | 2.37218796 |
| 115 | peptide catabolic process (GO:0043171) | 2.37058405 |
| 116 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.36635422 |
| 117 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.36090424 |
| 118 | magnesium ion transport (GO:0015693) | 2.35753001 |
| 119 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.35503116 |
| 120 | desmosome organization (GO:0002934) | 2.35426750 |
| 121 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.34151952 |
| 122 | regulation of insulin secretion (GO:0050796) | 2.34141207 |
| 123 | positive regulation of vesicle fusion (GO:0031340) | 2.33458602 |
| 124 | * localization within membrane (GO:0051668) | 2.33195769 |
| 125 | cerebellar Purkinje cell layer development (GO:0021680) | 2.32107414 |
| 126 | de novo protein folding (GO:0006458) | 2.31848521 |
| 127 | * melanosome localization (GO:0032400) | 2.31400040 |
| 128 | de novo posttranslational protein folding (GO:0051084) | 2.31381619 |
| 129 | type B pancreatic cell development (GO:0003323) | 2.31270234 |
| 130 | positive regulation of p38MAPK cascade (GO:1900745) | 2.29573012 |
| 131 | keratan sulfate catabolic process (GO:0042340) | 2.29569355 |
| 132 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.29508175 |
| 133 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.29164508 |
| 134 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.27951108 |
| 135 | regulation of metalloenzyme activity (GO:0048552) | 2.26477382 |
| 136 | peroxisome fission (GO:0016559) | 2.26430383 |
| 137 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.26250607 |
| 138 | vesicle organization (GO:0016050) | 2.25555468 |
| 139 | glutamate secretion (GO:0014047) | 2.24529148 |
| 140 | phenol-containing compound catabolic process (GO:0019336) | 2.24341390 |
| 141 | positive regulation of protein targeting to membrane (GO:0090314) | 2.23853674 |
| 142 | decidualization (GO:0046697) | 2.23789819 |
| 143 | short-term memory (GO:0007614) | 2.23593653 |
| 144 | regulation of sulfur metabolic process (GO:0042762) | 2.23434683 |
| 145 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.22919668 |
| 146 | synaptic vesicle maturation (GO:0016188) | 2.22732127 |
| 147 | * pigment granule localization (GO:0051875) | 2.22290725 |
| 148 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.20569112 |
| 149 | chondrocyte development (GO:0002063) | 2.19545176 |
| 150 | glandular epithelial cell development (GO:0002068) | 2.18885143 |
| 151 | anterograde synaptic vesicle transport (GO:0048490) | 2.18600112 |
| 152 | regulation of cell fate specification (GO:0042659) | 2.17635727 |
| 153 | * peptide secretion (GO:0002790) | 2.16961561 |
| 154 | muscle organ morphogenesis (GO:0048644) | 2.16872754 |
| 155 | cellular response to leptin stimulus (GO:0044320) | 2.16732627 |
| 156 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.16262788 |
| 157 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.16237731 |
| 158 | intraciliary transport (GO:0042073) | 2.15669576 |
| 159 | cellular copper ion homeostasis (GO:0006878) | 2.14901936 |
| 160 | response to dietary excess (GO:0002021) | 2.14510617 |
| 161 | regulation of mitochondrial fission (GO:0090140) | 2.14428465 |
| 162 | protein neddylation (GO:0045116) | 2.12846906 |
| 163 | neurofilament cytoskeleton organization (GO:0060052) | 2.10563152 |
| 164 | gamma-aminobutyric acid transport (GO:0015812) | 2.10189326 |
| 165 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.09512057 |
| 166 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.09354427 |
| 167 | regulation of cilium movement (GO:0003352) | 2.09338810 |
| 168 | vocalization behavior (GO:0071625) | 2.05674971 |
| 169 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.05286083 |
| 170 | positive regulation of protein depolymerization (GO:1901881) | 2.05123598 |
| 171 | * establishment of vesicle localization (GO:0051650) | 2.04016111 |
| 172 | synapse assembly (GO:0007416) | 2.03542803 |
| 173 | synaptic vesicle exocytosis (GO:0016079) | 2.02682828 |
| 174 | * vesicle localization (GO:0051648) | 2.01059988 |
| 175 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.00170196 |
| 176 | regulation of hexokinase activity (GO:1903299) | 1.98693247 |
| 177 | regulation of glucokinase activity (GO:0033131) | 1.98693247 |
| 178 | positive regulation of protein complex disassembly (GO:0043243) | 1.98631125 |
| 179 | protein K48-linked ubiquitination (GO:0070936) | 1.98034447 |
| 180 | positive regulation of TOR signaling (GO:0032008) | 1.97567008 |
| 181 | tricarboxylic acid cycle (GO:0006099) | 1.97517995 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.97429072 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.39021702 |
| 3 | CLOCK_20551151_ChIP-Seq_293T_Human | 4.08217003 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.46705484 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.11819116 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.95409665 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.73529326 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.72862781 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.56521270 |
| 10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.56023067 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.51337489 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.43525199 |
| 13 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 2.40775746 |
| 14 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35609286 |
| 15 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.31877273 |
| 16 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.29206219 |
| 17 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.28985093 |
| 18 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.20486261 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.14591825 |
| 20 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.12964680 |
| 21 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.10356097 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.09539317 |
| 23 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 2.09465640 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.08664748 |
| 25 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.08335671 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.07616310 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.06269364 |
| 28 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.05698381 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.05448562 |
| 30 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.98132815 |
| 31 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.94219194 |
| 32 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.92913662 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.91343626 |
| 34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.85818190 |
| 35 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.79716472 |
| 36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.78381834 |
| 37 | FUS_26573619_Chip-Seq_HEK293_Human | 1.77853876 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.77781200 |
| 39 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.77296016 |
| 40 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75824400 |
| 41 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.74637099 |
| 42 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.70448588 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.70207806 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.70207806 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.66310750 |
| 46 | ATF3_27146783_Chip-Seq_COLON_Human | 1.66018717 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.65691889 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.63952594 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.63297195 |
| 50 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.62337422 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60790658 |
| 52 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.60693475 |
| 53 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.60665995 |
| 54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.60394058 |
| 55 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57454840 |
| 56 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56264150 |
| 57 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51952597 |
| 58 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51858333 |
| 59 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51600429 |
| 60 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.51544277 |
| 61 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.50250880 |
| 62 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.49736329 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48856172 |
| 64 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.48682453 |
| 65 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.48196699 |
| 66 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.47877657 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.45957515 |
| 68 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.43663296 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.42600054 |
| 70 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.38979552 |
| 71 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.37827749 |
| 72 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.37683090 |
| 73 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37539290 |
| 74 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.37448716 |
| 75 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34496593 |
| 76 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.34413489 |
| 77 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.34413489 |
| 78 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.34145790 |
| 79 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.33946949 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33235215 |
| 81 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.31422595 |
| 82 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.31104119 |
| 83 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.30254071 |
| 84 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29708556 |
| 85 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.29650545 |
| 86 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29547091 |
| 87 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.28879810 |
| 88 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.28569146 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28566913 |
| 90 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.27714661 |
| 91 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26507232 |
| 92 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.26499163 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.26012607 |
| 94 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.25820178 |
| 95 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25546600 |
| 96 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.25390974 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24802388 |
| 98 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.24658142 |
| 99 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.24411856 |
| 100 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.23763459 |
| 101 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23430680 |
| 102 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.22658423 |
| 103 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20535733 |
| 104 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.19920286 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.19730150 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17640763 |
| 107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16623315 |
| 108 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.16293584 |
| 109 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16223166 |
| 110 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15505842 |
| 111 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15462089 |
| 112 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.15282999 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15234937 |
| 114 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15005985 |
| 115 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14889174 |
| 116 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14817188 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14817188 |
| 118 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14762945 |
| 119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.14580621 |
| 120 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14522817 |
| 121 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13732521 |
| 122 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12508221 |
| 123 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.12193719 |
| 124 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.11320361 |
| 125 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.10584034 |
| 126 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.10014557 |
| 127 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09290593 |
| 128 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08763228 |
| 129 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.08682650 |
| 130 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08530124 |
| 131 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08266883 |
| 132 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.07762305 |
| 133 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.06424104 |
| 134 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.05826248 |
| 135 | RXR_22108803_ChIP-Seq_LS180_Human | 1.05575447 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04673964 |
| 137 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04485339 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04237182 |
| 139 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.04208712 |
| 140 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04185554 |
| 141 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04081453 |
| 142 | * JUN_21703547_ChIP-Seq_K562_Human | 1.03433600 |
| 143 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.02656957 |
| 144 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02644530 |
| 145 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02556116 |
| 146 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02283007 |
| 147 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.01733132 |
| 148 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01010865 |
| 149 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99813288 |
| 150 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99667286 |
| 151 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99105985 |
| 152 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98996159 |
| 153 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.98930764 |
| 154 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.98895852 |
| 155 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97948610 |
| 156 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.97535568 |
| 157 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.96764618 |
| 158 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96352113 |
| 159 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.95893752 |
| 160 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95497109 |
| 161 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.95324237 |
| 162 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.94553326 |
| 163 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.94306833 |
| 164 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93920257 |
| 165 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93753910 |
| 166 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.93514408 |
| 167 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93079506 |
| 168 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.92759234 |
| 169 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.91692755 |
| 170 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91393456 |
| 171 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.91331291 |
| 172 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.91229458 |
| 173 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.90163516 |
| 174 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89366510 |
| 175 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.88893119 |
| 176 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88509219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 4.05189419 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 3.44058411 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.17265851 |
| 4 | MP0009780_abnormal_chondrocyte_physiolo | 3.04738447 |
| 5 | MP0003283_abnormal_digestive_organ | 2.85064088 |
| 6 | MP0000013_abnormal_adipose_tissue | 2.84132350 |
| 7 | MP0002909_abnormal_adrenal_gland | 2.79100061 |
| 8 | MP0003195_calcinosis | 2.72948962 |
| 9 | MP0004270_analgesia | 2.62839736 |
| 10 | MP0006054_spinal_hemorrhage | 2.46240701 |
| 11 | MP0001529_abnormal_vocalization | 2.33491303 |
| 12 | MP0004043_abnormal_pH_regulation | 2.32909724 |
| 13 | MP0001984_abnormal_olfaction | 2.25062211 |
| 14 | MP0004264_abnormal_extraembryonic_tissu | 2.22117841 |
| 15 | MP0002896_abnormal_bone_mineralization | 2.21857841 |
| 16 | MP0008438_abnormal_cutaneous_collagen | 2.18842703 |
| 17 | MP0005220_abnormal_exocrine_pancreas | 2.18100208 |
| 18 | MP0005499_abnormal_olfactory_system | 2.17503229 |
| 19 | MP0005394_taste/olfaction_phenotype | 2.17503229 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 2.14597902 |
| 21 | MP0003941_abnormal_skin_development | 2.12883237 |
| 22 | MP0003221_abnormal_cardiomyocyte_apopto | 2.03754836 |
| 23 | MP0010386_abnormal_urinary_bladder | 2.03157598 |
| 24 | MP0001944_abnormal_pancreas_morphology | 2.01531561 |
| 25 | MP0005275_abnormal_skin_tensile | 2.00397259 |
| 26 | MP0002102_abnormal_ear_morphology | 1.96496991 |
| 27 | MP0008789_abnormal_olfactory_epithelium | 1.96163451 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.94289910 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.92128346 |
| 30 | MP0004272_abnormal_basement_membrane | 1.92085213 |
| 31 | MP0002693_abnormal_pancreas_physiology | 1.91524180 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.87352364 |
| 33 | MP0003880_abnormal_central_pattern | 1.87008231 |
| 34 | MP0000647_abnormal_sebaceous_gland | 1.69684608 |
| 35 | MP0005076_abnormal_cell_differentiation | 1.69548410 |
| 36 | MP0002139_abnormal_hepatobiliary_system | 1.65374176 |
| 37 | MP0009046_muscle_twitch | 1.62259887 |
| 38 | MP0005084_abnormal_gallbladder_morpholo | 1.60146425 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.56626595 |
| 40 | MP0002822_catalepsy | 1.54439446 |
| 41 | MP0003121_genomic_imprinting | 1.48661409 |
| 42 | MP0003252_abnormal_bile_duct | 1.46735857 |
| 43 | MP0005367_renal/urinary_system_phenotyp | 1.46582963 |
| 44 | MP0000516_abnormal_urinary_system | 1.46582963 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.45795296 |
| 46 | MP0003186_abnormal_redox_activity | 1.44226011 |
| 47 | MP0001188_hyperpigmentation | 1.42225208 |
| 48 | MP0005248_abnormal_Harderian_gland | 1.42220652 |
| 49 | MP0000372_irregular_coat_pigmentation | 1.41764681 |
| 50 | MP0003122_maternal_imprinting | 1.41717111 |
| 51 | MP0004859_abnormal_synaptic_plasticity | 1.40842047 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.38529023 |
| 53 | MP0005503_abnormal_tendon_morphology | 1.37660112 |
| 54 | MP0001756_abnormal_urination | 1.37188185 |
| 55 | MP0009643_abnormal_urine_homeostasis | 1.34574361 |
| 56 | MP0001299_abnormal_eye_distance/ | 1.31926577 |
| 57 | MP0005187_abnormal_penis_morphology | 1.31586009 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 1.30784871 |
| 59 | MP0005365_abnormal_bile_salt | 1.29440522 |
| 60 | MP0009384_cardiac_valve_regurgitation | 1.28327454 |
| 61 | MP0004782_abnormal_surfactant_physiolog | 1.27424110 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.24824790 |
| 63 | MP0002233_abnormal_nose_morphology | 1.23980082 |
| 64 | MP0004233_abnormal_muscle_weight | 1.20766620 |
| 65 | MP0005257_abnormal_intraocular_pressure | 1.17821503 |
| 66 | MP0009053_abnormal_anal_canal | 1.17406353 |
| 67 | MP0000537_abnormal_urethra_morphology | 1.15334155 |
| 68 | MP0005083_abnormal_biliary_tract | 1.14315563 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.12542223 |
| 70 | MP0001727_abnormal_embryo_implantation | 1.10106824 |
| 71 | MP0003385_abnormal_body_wall | 1.09164727 |
| 72 | MP0005085_abnormal_gallbladder_physiolo | 1.09078723 |
| 73 | MP0002734_abnormal_mechanical_nocicepti | 1.06932899 |
| 74 | MP0004215_abnormal_myocardial_fiber | 1.04306358 |
| 75 | MP0005360_urolithiasis | 1.02857607 |
| 76 | MP0008961_abnormal_basal_metabolism | 1.02539351 |
| 77 | MP0004133_heterotaxia | 1.02434853 |
| 78 | MP0000538_abnormal_urinary_bladder | 1.02157735 |
| 79 | MP0000778_abnormal_nervous_system | 1.02012069 |
| 80 | MP0000462_abnormal_digestive_system | 1.01341063 |
| 81 | MP0003119_abnormal_digestive_system | 0.98115320 |
| 82 | MP0009840_abnormal_foam_cell | 0.98081919 |
| 83 | MP0004858_abnormal_nervous_system | 0.96864563 |
| 84 | MP0003011_delayed_dark_adaptation | 0.96225771 |
| 85 | MP0005332_abnormal_amino_acid | 0.95450217 |
| 86 | MP0003868_abnormal_feces_composition | 0.95009945 |
| 87 | MP0003191_abnormal_cellular_cholesterol | 0.94822620 |
| 88 | MP0002837_dystrophic_cardiac_calcinosis | 0.94732450 |
| 89 | MP0002751_abnormal_autonomic_nervous | 0.94434389 |
| 90 | MP0003567_abnormal_fetal_cardiomyocyte | 0.93418527 |
| 91 | MP0001765_abnormal_ion_homeostasis | 0.93272802 |
| 92 | MP0005408_hypopigmentation | 0.92208060 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.91996526 |
| 94 | MP0001881_abnormal_mammary_gland | 0.90606940 |
| 95 | MP0001849_ear_inflammation | 0.90590535 |
| 96 | MP0005253_abnormal_eye_physiology | 0.90459862 |
| 97 | MP0003890_abnormal_embryonic-extraembry | 0.89595492 |
| 98 | MP0003123_paternal_imprinting | 0.89086396 |
| 99 | MP0005379_endocrine/exocrine_gland_phen | 0.88487186 |
| 100 | MP0003755_abnormal_palate_morphology | 0.88124468 |
| 101 | MP0004130_abnormal_muscle_cell | 0.87862892 |
| 102 | MP0000613_abnormal_salivary_gland | 0.87548434 |
| 103 | MP0002796_impaired_skin_barrier | 0.87225414 |
| 104 | MP0004484_altered_response_of | 0.87101947 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.86758512 |
| 106 | MP0004185_abnormal_adipocyte_glucose | 0.86459000 |
| 107 | MP0002295_abnormal_pulmonary_circulatio | 0.86214071 |
| 108 | MP0000427_abnormal_hair_cycle | 0.85952497 |
| 109 | MP0005501_abnormal_skin_physiology | 0.85053779 |
| 110 | MP0000163_abnormal_cartilage_morphology | 0.85005189 |
| 111 | MP0004924_abnormal_behavior | 0.84842873 |
| 112 | MP0005386_behavior/neurological_phenoty | 0.84842873 |
| 113 | MP0004019_abnormal_vitamin_homeostasis | 0.84741579 |
| 114 | MP0003091_abnormal_cell_migration | 0.84430193 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.84348060 |
| 116 | MP0003950_abnormal_plasma_membrane | 0.83898527 |
| 117 | MP0003787_abnormal_imprinting | 0.82932558 |
| 118 | MP0004811_abnormal_neuron_physiology | 0.81914247 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.81732701 |
| 120 | MP0005023_abnormal_wound_healing | 0.81103732 |
| 121 | MP0008004_abnormal_stomach_pH | 0.80165382 |
| 122 | MP0000678_abnormal_parathyroid_gland | 0.79851538 |
| 123 | MP0000604_amyloidosis | 0.79575065 |
| 124 | MP0003953_abnormal_hormone_level | 0.79563142 |
| 125 | MP0000358_abnormal_cell_content/ | 0.78923548 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.78021345 |
| 127 | MP0002928_abnormal_bile_duct | 0.77198387 |
| 128 | MP0003959_abnormal_lean_body | 0.77062044 |
| 129 | MP0005645_abnormal_hypothalamus_physiol | 0.77021120 |
| 130 | MP0002557_abnormal_social/conspecific_i | 0.76679032 |
| 131 | MP0002736_abnormal_nociception_after | 0.75874544 |
| 132 | MP0005423_abnormal_somatic_nervous | 0.75678833 |
| 133 | MP0004147_increased_porphyrin_level | 0.75649756 |
| 134 | MP0003718_maternal_effect | 0.75640547 |
| 135 | MP0008260_abnormal_autophagy | 0.75100063 |
| 136 | MP0003795_abnormal_bone_structure | 0.74966836 |
| 137 | MP0003279_aneurysm | 0.74719159 |
| 138 | MP0002090_abnormal_vision | 0.74511300 |
| 139 | MP0000049_abnormal_middle_ear | 0.73928482 |
| 140 | MP0002572_abnormal_emotion/affect_behav | 0.72763304 |
| 141 | MP0002115_abnormal_skeleton_extremities | 0.71860487 |
| 142 | MP0005623_abnormal_meninges_morphology | 0.71098501 |
| 143 | MP0001986_abnormal_taste_sensitivity | 0.70846953 |
| 144 | MP0005508_abnormal_skeleton_morphology | 0.70379906 |
| 145 | MP0001177_atelectasis | 0.70172958 |
| 146 | MP0002272_abnormal_nervous_system | 0.70114302 |
| 147 | MP0002177_abnormal_outer_ear | 0.69963959 |
| 148 | MP0001324_abnormal_eye_pigmentation | 0.69797139 |
| 149 | MP0002184_abnormal_innervation | 0.69767424 |
| 150 | MP0001542_abnormal_bone_strength | 0.69629229 |
| 151 | MP0000534_abnormal_ureter_morphology | 0.69167956 |
| 152 | MP0010329_abnormal_lipoprotein_level | 0.69003114 |
| 153 | MP0001958_emphysema | 0.67724718 |
| 154 | MP0008995_early_reproductive_senescence | 0.66666050 |
| 155 | MP0002069_abnormal_eating/drinking_beha | 0.66305086 |
| 156 | MP0005448_abnormal_energy_balance | 0.66072098 |
| 157 | MP0002060_abnormal_skin_morphology | 0.65949433 |
| 158 | MP0002254_reproductive_system_inflammat | 0.65528192 |
| 159 | MP0000230_abnormal_systemic_arterial | 0.65476685 |
| 160 | MP0002098_abnormal_vibrissa_morphology | 0.65026452 |
| 161 | MP0010368_abnormal_lymphatic_system | 0.64991650 |
| 162 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64928841 |
| 163 | MP0002168_other_aberrant_phenotype | 0.64826207 |
| 164 | MP0005167_abnormal_blood-brain_barrier | 0.62788337 |
| 165 | MP0003806_abnormal_nucleotide_metabolis | 0.62615951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 4.52794083 |
| 2 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.46072780 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.45034544 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.40674598 |
| 5 | Symptomatic seizures (HP:0011145) | 3.82371417 |
| 6 | Cortical dysplasia (HP:0002539) | 3.56413273 |
| 7 | Hyperglycemia (HP:0003074) | 3.42434601 |
| 8 | Increased serum pyruvate (HP:0003542) | 3.38803178 |
| 9 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.27797066 |
| 10 | Mucopolysacchariduria (HP:0008155) | 3.27797066 |
| 11 | Abnormality of glycolysis (HP:0004366) | 3.21293349 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.20920470 |
| 13 | Ketoacidosis (HP:0001993) | 3.15310364 |
| 14 | Polyphagia (HP:0002591) | 3.05528350 |
| 15 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.94105434 |
| 16 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.94105434 |
| 17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.94105434 |
| 18 | Protrusio acetabuli (HP:0003179) | 2.93681823 |
| 19 | Tetraparesis (HP:0002273) | 2.88362200 |
| 20 | Gout (HP:0001997) | 2.85779938 |
| 21 | Agitation (HP:0000713) | 2.83244706 |
| 22 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.72856760 |
| 23 | Gait imbalance (HP:0002141) | 2.70022714 |
| 24 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.69690215 |
| 25 | Abnormal pancreas size (HP:0012094) | 2.68752478 |
| 26 | Hand muscle atrophy (HP:0009130) | 2.66789489 |
| 27 | Hydroxyprolinuria (HP:0003080) | 2.60988921 |
| 28 | Abnormality of proline metabolism (HP:0010907) | 2.60988921 |
| 29 | Congenital primary aphakia (HP:0007707) | 2.59573169 |
| 30 | Nephrogenic diabetes insipidus (HP:0009806) | 2.58778829 |
| 31 | Late onset (HP:0003584) | 2.56730774 |
| 32 | Mutism (HP:0002300) | 2.56238698 |
| 33 | Cervical subluxation (HP:0003308) | 2.51542243 |
| 34 | Papillary thyroid carcinoma (HP:0002895) | 2.48248436 |
| 35 | Termporal pattern (HP:0011008) | 2.45965711 |
| 36 | Insidious onset (HP:0003587) | 2.45965711 |
| 37 | Hyperparathyroidism (HP:0000843) | 2.40473473 |
| 38 | Autoamputation (HP:0001218) | 2.39400553 |
| 39 | Intrahepatic cholestasis (HP:0001406) | 2.38836522 |
| 40 | Limb dystonia (HP:0002451) | 2.36339344 |
| 41 | Medial flaring of the eyebrow (HP:0010747) | 2.34800606 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 2.30424472 |
| 43 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.29442243 |
| 44 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.29442243 |
| 45 | Thoracolumbar scoliosis (HP:0002944) | 2.28555570 |
| 46 | Poor suck (HP:0002033) | 2.27708449 |
| 47 | Right ventricular cardiomyopathy (HP:0011663) | 2.26774804 |
| 48 | Protuberant abdomen (HP:0001538) | 2.26121931 |
| 49 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.24935810 |
| 50 | Abnormality of the intrinsic pathway (HP:0010989) | 2.24525627 |
| 51 | Delayed gross motor development (HP:0002194) | 2.23120634 |
| 52 | Abdominal distention (HP:0003270) | 2.22523734 |
| 53 | Upper limb muscle weakness (HP:0003484) | 2.20607317 |
| 54 | Hypercortisolism (HP:0001578) | 2.19866788 |
| 55 | Adrenal hypoplasia (HP:0000835) | 2.18656929 |
| 56 | Genital tract atresia (HP:0001827) | 2.17660416 |
| 57 | Sensorimotor neuropathy (HP:0007141) | 2.16101737 |
| 58 | Hepatoblastoma (HP:0002884) | 2.15954237 |
| 59 | Premature rupture of membranes (HP:0001788) | 2.14039702 |
| 60 | Vaginal atresia (HP:0000148) | 2.13912161 |
| 61 | Cerebral aneurysm (HP:0004944) | 2.13294655 |
| 62 | Drooling (HP:0002307) | 2.11648603 |
| 63 | Thyroid carcinoma (HP:0002890) | 2.11290554 |
| 64 | Back pain (HP:0003418) | 2.10555731 |
| 65 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.09951636 |
| 66 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.09951636 |
| 67 | Hypokalemia (HP:0002900) | 2.09413901 |
| 68 | Epidermoid cyst (HP:0200040) | 2.08846959 |
| 69 | Atrophic scars (HP:0001075) | 2.04580625 |
| 70 | Generalized aminoaciduria (HP:0002909) | 2.02120094 |
| 71 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.02072410 |
| 72 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00425100 |
| 73 | Aortic aneurysm (HP:0004942) | 1.99858846 |
| 74 | Restlessness (HP:0000711) | 1.99654720 |
| 75 | Thin bony cortex (HP:0002753) | 1.98670955 |
| 76 | Abnormality of purine metabolism (HP:0004352) | 1.98481620 |
| 77 | Pheochromocytoma (HP:0002666) | 1.98388782 |
| 78 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.97819746 |
| 79 | Retinal atrophy (HP:0001105) | 1.97640303 |
| 80 | Papilledema (HP:0001085) | 1.97506349 |
| 81 | Shoulder girdle muscle weakness (HP:0003547) | 1.96386838 |
| 82 | Vacuolated lymphocytes (HP:0001922) | 1.95916822 |
| 83 | Spastic tetraplegia (HP:0002510) | 1.94519228 |
| 84 | Labial hypoplasia (HP:0000066) | 1.93624134 |
| 85 | Broad alveolar ridges (HP:0000187) | 1.93561126 |
| 86 | Muscular hypotonia of the trunk (HP:0008936) | 1.93311237 |
| 87 | Hyperactive renin-angiotensin system (HP:0000841) | 1.92085912 |
| 88 | Proximal tubulopathy (HP:0000114) | 1.92079941 |
| 89 | Failure to thrive in infancy (HP:0001531) | 1.91497930 |
| 90 | Decreased muscle mass (HP:0003199) | 1.90656862 |
| 91 | Upper limb amyotrophy (HP:0009129) | 1.90367150 |
| 92 | Distal upper limb amyotrophy (HP:0007149) | 1.90367150 |
| 93 | Amyotrophic lateral sclerosis (HP:0007354) | 1.89880379 |
| 94 | Vertebral compression fractures (HP:0002953) | 1.89521647 |
| 95 | Beaking of vertebral bodies (HP:0004568) | 1.89467734 |
| 96 | Skin nodule (HP:0200036) | 1.88788275 |
| 97 | Aneurysm (HP:0002617) | 1.88592025 |
| 98 | Follicular hyperkeratosis (HP:0007502) | 1.87938874 |
| 99 | Hyperalaninemia (HP:0003348) | 1.87751357 |
| 100 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.87751357 |
| 101 | Abnormality of alanine metabolism (HP:0010916) | 1.87751357 |
| 102 | Striae distensae (HP:0001065) | 1.87378336 |
| 103 | Epiphyseal dysplasia (HP:0002656) | 1.87075169 |
| 104 | Neoplasm of the adrenal gland (HP:0100631) | 1.86403344 |
| 105 | Insulin resistance (HP:0000855) | 1.86123840 |
| 106 | Patchy hypopigmentation of hair (HP:0011365) | 1.85397495 |
| 107 | Hypsarrhythmia (HP:0002521) | 1.84791479 |
| 108 | Intestinal atresia (HP:0011100) | 1.84442219 |
| 109 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.82839662 |
| 110 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.82839662 |
| 111 | Ketosis (HP:0001946) | 1.81708725 |
| 112 | Hypothermia (HP:0002045) | 1.81655537 |
| 113 | Vascular tortuosity (HP:0004948) | 1.80682004 |
| 114 | EEG with generalized epileptiform discharges (HP:0011198) | 1.80478145 |
| 115 | Absent eyebrow (HP:0002223) | 1.80147499 |
| 116 | Acute necrotizing encephalopathy (HP:0006965) | 1.79655909 |
| 117 | Excessive salivation (HP:0003781) | 1.79066693 |
| 118 | Macroorchidism (HP:0000053) | 1.78339290 |
| 119 | Overgrowth (HP:0001548) | 1.78236204 |
| 120 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77736186 |
| 121 | Osteopenia (HP:0000938) | 1.77225917 |
| 122 | Split foot (HP:0001839) | 1.77110600 |
| 123 | Cupped ribs (HP:0000887) | 1.76855349 |
| 124 | Abnormality of the common coagulation pathway (HP:0010990) | 1.76717723 |
| 125 | Exostoses (HP:0100777) | 1.76349804 |
| 126 | Exocrine pancreatic insufficiency (HP:0001738) | 1.76002911 |
| 127 | Methylmalonic acidemia (HP:0002912) | 1.75805967 |
| 128 | Congenital glaucoma (HP:0001087) | 1.75221072 |
| 129 | Urinary urgency (HP:0000012) | 1.75149050 |
| 130 | Acute encephalopathy (HP:0006846) | 1.74321401 |
| 131 | Long toe (HP:0010511) | 1.73393017 |
| 132 | Dilatation of the ascending aorta (HP:0005111) | 1.73194304 |
| 133 | Arterial tortuosity (HP:0005116) | 1.73107721 |
| 134 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.72845304 |
| 135 | Enlarged penis (HP:0000040) | 1.72065870 |
| 136 | Postnatal microcephaly (HP:0005484) | 1.71240783 |
| 137 | Hypotension (HP:0002615) | 1.71134028 |
| 138 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.70557110 |
| 139 | Vertebral hypoplasia (HP:0008417) | 1.70557110 |
| 140 | Disinhibition (HP:0000734) | 1.69984328 |
| 141 | Xanthomatosis (HP:0000991) | 1.69071900 |
| 142 | Metaphyseal cupping (HP:0003021) | 1.68671696 |
| 143 | Short tibia (HP:0005736) | 1.68222692 |
| 144 | Hypoplastic female external genitalia (HP:0012815) | 1.68119457 |
| 145 | Severe short stature (HP:0003510) | 1.67954877 |
| 146 | Epileptiform EEG discharges (HP:0011182) | 1.67856688 |
| 147 | Hyperglycinemia (HP:0002154) | 1.66999098 |
| 148 | Spinal cord compression (HP:0002176) | 1.66695043 |
| 149 | Decreased circulating renin level (HP:0003351) | 1.65697727 |
| 150 | Abnormality of glycolipid metabolism (HP:0010969) | 1.65565015 |
| 151 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.65565015 |
| 152 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.65565015 |
| 153 | Degeneration of anterior horn cells (HP:0002398) | 1.65252719 |
| 154 | Abnormality of the anterior horn cell (HP:0006802) | 1.65252719 |
| 155 | Platyspondyly (HP:0000926) | 1.64269868 |
| 156 | Hypophosphatemia (HP:0002148) | 1.64111304 |
| 157 | Bifid tongue (HP:0010297) | 1.64012870 |
| 158 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.63905365 |
| 159 | Specific learning disability (HP:0001328) | 1.63798113 |
| 160 | Ulnar claw (HP:0001178) | 1.63356151 |
| 161 | Growth hormone excess (HP:0000845) | 1.63010288 |
| 162 | Progressive macrocephaly (HP:0004481) | 1.61462194 |
| 163 | Hypoplasia of the odontoid process (HP:0003311) | 1.60948873 |
| 164 | Abnormality of chloride homeostasis (HP:0011422) | 1.60639745 |
| 165 | Broad foot (HP:0001769) | 1.60232508 |
| 166 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.60144208 |
| 167 | Limb-girdle muscle atrophy (HP:0003797) | 1.59772788 |
| 168 | Decreased testicular size (HP:0008734) | 1.59288450 |
| 169 | Abnormal protein glycosylation (HP:0012346) | 1.59216670 |
| 170 | Abnormal glycosylation (HP:0012345) | 1.59216670 |
| 171 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.59216670 |
| 172 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.59216670 |
| 173 | Hyperextensible skin (HP:0000974) | 1.59043484 |
| 174 | Flat acetabular roof (HP:0003180) | 1.58691654 |
| 175 | Adrenal overactivity (HP:0002717) | 1.58592052 |
| 176 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.58025145 |
| 177 | Ovoid vertebral bodies (HP:0003300) | 1.57596758 |
| 178 | Lymphangioma (HP:0100764) | 1.56802406 |
| 179 | Spastic diplegia (HP:0001264) | 1.55926190 |
| 180 | Action tremor (HP:0002345) | 1.55020724 |
| 181 | Hydroureter (HP:0000072) | 1.54570047 |
| 182 | Abnormality of the labia (HP:0000058) | 1.54447568 |
| 183 | Abnormality of the corticospinal tract (HP:0002492) | 1.53602708 |
| 184 | Apathy (HP:0000741) | 1.52481514 |
| 185 | Curly hair (HP:0002212) | 1.52479089 |
| 186 | Double outlet right ventricle (HP:0001719) | 1.50794014 |
| 187 | Congenital malformation of the right heart (HP:0011723) | 1.50794014 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 4.27727409 |
| 2 | ERN1 | 3.68172636 |
| 3 | FRK | 3.51180545 |
| 4 | SCYL2 | 3.14161238 |
| 5 | MAP3K2 | 2.95788629 |
| 6 | INSRR | 2.77630185 |
| 7 | CASK | 2.70010830 |
| 8 | TRIB3 | 2.52793943 |
| 9 | MAP3K4 | 2.36224291 |
| 10 | MAP2K7 | 2.31774369 |
| 11 | MAP4K2 | 2.31285016 |
| 12 | NTRK1 | 2.21907283 |
| 13 | SIK3 | 2.21902670 |
| 14 | FER | 2.15034693 |
| 15 | PTK2 | 2.10189442 |
| 16 | MAPK15 | 2.09482867 |
| 17 | LATS1 | 2.04029855 |
| 18 | TESK1 | 2.03445923 |
| 19 | PASK | 2.00364190 |
| 20 | CSNK1G2 | 2.00249675 |
| 21 | CSNK1G3 | 1.99873759 |
| 22 | EPHA2 | 1.98250521 |
| 23 | CSNK1A1L | 1.91068178 |
| 24 | PDGFRA | 1.87753032 |
| 25 | FLT3 | 1.80311796 |
| 26 | WNK3 | 1.79345623 |
| 27 | SRPK1 | 1.78912964 |
| 28 | MET | 1.77561780 |
| 29 | RIPK1 | 1.74286627 |
| 30 | NEK1 | 1.70864305 |
| 31 | PKN2 | 1.69737836 |
| 32 | CSNK1G1 | 1.69700547 |
| 33 | KSR2 | 1.68444149 |
| 34 | MAP3K9 | 1.68003213 |
| 35 | ERBB3 | 1.67525755 |
| 36 | PAK3 | 1.59884983 |
| 37 | LATS2 | 1.57857005 |
| 38 | PIM2 | 1.55579399 |
| 39 | PTK6 | 1.54990849 |
| 40 | DDR2 | 1.52858472 |
| 41 | WNK4 | 1.52786381 |
| 42 | AKT3 | 1.47145765 |
| 43 | LIMK1 | 1.46949340 |
| 44 | PRKD3 | 1.44303224 |
| 45 | PBK | 1.42607929 |
| 46 | CAMKK2 | 1.39662463 |
| 47 | EPHA3 | 1.37935818 |
| 48 | MAP3K3 | 1.32687084 |
| 49 | MAP3K1 | 1.19474723 |
| 50 | MAPKAPK3 | 1.18695163 |
| 51 | NEK9 | 1.16691291 |
| 52 | MAP2K1 | 1.14692401 |
| 53 | RET | 1.14685374 |
| 54 | MAP3K6 | 1.13362955 |
| 55 | MINK1 | 1.09412346 |
| 56 | BCKDK | 1.07001936 |
| 57 | MST1R | 1.05941002 |
| 58 | MYLK | 1.01430565 |
| 59 | BRSK2 | 1.00093480 |
| 60 | DYRK1B | 0.99487995 |
| 61 | EIF2AK1 | 0.97959485 |
| 62 | DYRK3 | 0.97005532 |
| 63 | SIK1 | 0.96551783 |
| 64 | STK24 | 0.95021280 |
| 65 | HIPK2 | 0.94191767 |
| 66 | KSR1 | 0.93223186 |
| 67 | TNIK | 0.93073834 |
| 68 | PRKCG | 0.92666912 |
| 69 | PRKG2 | 0.91238293 |
| 70 | GRK7 | 0.89725705 |
| 71 | ACVR1B | 0.89090384 |
| 72 | BMPR1B | 0.87679324 |
| 73 | PAK4 | 0.87506616 |
| 74 | EPHB2 | 0.86999033 |
| 75 | DYRK2 | 0.86247282 |
| 76 | MAPK13 | 0.84099721 |
| 77 | PDK2 | 0.83130672 |
| 78 | PIK3CG | 0.81540320 |
| 79 | ARAF | 0.81221901 |
| 80 | MAP2K2 | 0.80920554 |
| 81 | PINK1 | 0.80717186 |
| 82 | MAP3K5 | 0.79461512 |
| 83 | RPS6KA4 | 0.78465496 |
| 84 | STK38L | 0.75538868 |
| 85 | PLK2 | 0.73114457 |
| 86 | FGFR1 | 0.71682549 |
| 87 | LMTK2 | 0.71281303 |
| 88 | TIE1 | 0.70866971 |
| 89 | CDK18 | 0.70420248 |
| 90 | CDK6 | 0.69259765 |
| 91 | MARK1 | 0.66124945 |
| 92 | CAMK2A | 0.63991432 |
| 93 | GSK3A | 0.62511080 |
| 94 | TSSK6 | 0.62302480 |
| 95 | ERBB4 | 0.61298660 |
| 96 | CAMKK1 | 0.60450129 |
| 97 | CAMK2D | 0.59661423 |
| 98 | MKNK1 | 0.59114728 |
| 99 | MKNK2 | 0.56466930 |
| 100 | BCR | 0.56423474 |
| 101 | CAMK2B | 0.55163105 |
| 102 | PIK3CA | 0.54671032 |
| 103 | EPHA4 | 0.54338904 |
| 104 | GRK1 | 0.54049442 |
| 105 | MTOR | 0.53544865 |
| 106 | IRAK1 | 0.52967779 |
| 107 | MAP2K4 | 0.52720061 |
| 108 | TAOK3 | 0.52588427 |
| 109 | TGFBR2 | 0.52313521 |
| 110 | CDK15 | 0.51659859 |
| 111 | PAK2 | 0.50150731 |
| 112 | STK39 | 0.50135014 |
| 113 | FGFR3 | 0.49935739 |
| 114 | CDK14 | 0.49726676 |
| 115 | CAMK2G | 0.49201377 |
| 116 | LRRK2 | 0.48918577 |
| 117 | PAK6 | 0.48130366 |
| 118 | BUB1 | 0.47677989 |
| 119 | OXSR1 | 0.47504137 |
| 120 | PDGFRB | 0.46371709 |
| 121 | NTRK3 | 0.46178182 |
| 122 | CDK19 | 0.46047530 |
| 123 | CDK5 | 0.46007917 |
| 124 | TAOK1 | 0.46002838 |
| 125 | ADRBK2 | 0.45493070 |
| 126 | PRKCE | 0.45160655 |
| 127 | CDK11A | 0.44698148 |
| 128 | STK3 | 0.43956543 |
| 129 | ALK | 0.43394165 |
| 130 | MST4 | 0.41395287 |
| 131 | TGFBR1 | 0.41248338 |
| 132 | DMPK | 0.41222875 |
| 133 | DYRK1A | 0.40476230 |
| 134 | EGFR | 0.40421609 |
| 135 | STK16 | 0.39689954 |
| 136 | PRKCI | 0.38818144 |
| 137 | CSNK1A1 | 0.38601324 |
| 138 | EIF2AK3 | 0.38556836 |
| 139 | IGF1R | 0.34021788 |
| 140 | FGFR4 | 0.33426667 |
| 141 | PDPK1 | 0.31969403 |
| 142 | ERBB2 | 0.31887364 |
| 143 | SGK3 | 0.30943183 |
| 144 | PLK3 | 0.30142555 |
| 145 | JAK2 | 0.29382853 |
| 146 | PRKCH | 0.28494104 |
| 147 | UHMK1 | 0.28424566 |
| 148 | PRKACG | 0.27625730 |
| 149 | ABL2 | 0.25450043 |
| 150 | MAP3K12 | 0.25123934 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.85565445 |
| 2 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.87113931 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85721993 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.74412817 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.59488543 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.55361213 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.54910292 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.50731986 |
| 9 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.34164443 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.17061658 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.14316862 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.89898343 |
| 13 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.88186622 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.80196462 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.79328984 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.75728055 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.65433033 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64344869 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.59622785 |
| 20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49956482 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.42688016 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41478831 |
| 23 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.38179396 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.36012769 |
| 25 | Nicotine addiction_Homo sapiens_hsa05033 | 1.34751486 |
| 26 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.33642905 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.32854987 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.27063484 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.24140656 |
| 30 | Adherens junction_Homo sapiens_hsa04520 | 1.23827821 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.21205366 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.19939650 |
| 33 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.19159480 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.18407928 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.15802225 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14892731 |
| 37 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.14764648 |
| 38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14233084 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.12933894 |
| 40 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.12690755 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.12482094 |
| 42 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.11190374 |
| 43 | GABAergic synapse_Homo sapiens_hsa04727 | 1.10537095 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.09372330 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07475971 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04205380 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01285724 |
| 48 | Thyroid cancer_Homo sapiens_hsa05216 | 0.99865896 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99688415 |
| 50 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99602714 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98279318 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96389219 |
| 53 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.96031619 |
| 54 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95782437 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.95653722 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.95000288 |
| 57 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92844795 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90845972 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90640075 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.88847839 |
| 61 | Mineral absorption_Homo sapiens_hsa04978 | 0.87898500 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87605224 |
| 63 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.87389411 |
| 64 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.84316974 |
| 65 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84242436 |
| 66 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.83521405 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82816429 |
| 68 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81606718 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81457146 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.80232020 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80222614 |
| 72 | Alzheimers disease_Homo sapiens_hsa05010 | 0.79892255 |
| 73 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.79420040 |
| 74 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.79356885 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.79208402 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78380502 |
| 77 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.78357259 |
| 78 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.78239685 |
| 79 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77629849 |
| 80 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77387263 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.77137462 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.76523097 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76507385 |
| 84 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74680011 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.74635373 |
| 86 | Basal transcription factors_Homo sapiens_hsa03022 | 0.73967413 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73786058 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72136961 |
| 89 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.71687942 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70785210 |
| 91 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69597952 |
| 92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67281309 |
| 93 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67180393 |
| 94 | Bile secretion_Homo sapiens_hsa04976 | 0.65294228 |
| 95 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64574912 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64532958 |
| 97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64466298 |
| 98 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.64080784 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.63964631 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.63123385 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62219907 |
| 102 | Tight junction_Homo sapiens_hsa04530 | 0.62157373 |
| 103 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.61876357 |
| 104 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61058843 |
| 105 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.60987777 |
| 106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59967365 |
| 107 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59886161 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.59542812 |
| 109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.58900985 |
| 110 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.58640241 |
| 111 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.57873125 |
| 112 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57591723 |
| 113 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57258019 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57136968 |
| 115 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56114941 |
| 116 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56014020 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55891976 |
| 118 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.55550120 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55367790 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.55254517 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53199953 |
| 122 | Shigellosis_Homo sapiens_hsa05131 | 0.51902018 |
| 123 | Endocytosis_Homo sapiens_hsa04144 | 0.51399979 |
| 124 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51288473 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51142242 |
| 126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.49754802 |
| 127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49221691 |
| 128 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48621432 |
| 129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.48119350 |
| 130 | Gap junction_Homo sapiens_hsa04540 | 0.45578873 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.45481681 |
| 132 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45275509 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.45054314 |
| 134 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43341537 |
| 135 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.42159284 |
| 136 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41784313 |
| 137 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41512358 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40705624 |
| 139 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.39781802 |
| 140 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.39394439 |
| 141 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.39095379 |
| 142 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.38796686 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38081384 |
| 144 | Melanogenesis_Homo sapiens_hsa04916 | 0.37380765 |
| 145 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37148938 |
| 146 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37044985 |
| 147 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.36150209 |
| 148 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.35054567 |
| 149 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34707989 |
| 150 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33627852 |

